Skip to main content
. 2024 Sep 9;47(4):e20230339. doi: 10.1590/1678-4685-GMB-2023-0339

Table 2 - . Serum levels of individuals with DS.

Individual us-CRP (mg/dL) TSH (µUI/mL) Free T4 (ng/dL) HbA1c (%) EMG (mg/dL)
1 0.05 6.46* 1.04 5.2% 103
2 0.02 2.95 1.11 5.3% 104
3 <0.02 4.14 1.23 5.5% 110
4 0.08 2.1 1.59 5.4% 109
5 0.19 1.45 0.92 5.1% 99
6 0.02 5.31* 0.86 4.5% 82
7 0.63* 5.38* 1.32 5.2% 102
8 0.79* 6.73* 1.44 8.0% 183*
9 0.41* 3.01 0.94 4.9% 95
10 0.17 49.32* 0.77* 5.0% 97
11 0.33* 3.11 1.16 5.3% 104
12 0.02 4 1.12 5.0% 97
13 0.95* 3.61 1.56 5.0% 96
14 0.55* 4.47* 1.13 5.6% 114
15 0.27* 2.97 1.14 5.8% 119
16 0.15 16.96* 1.04 4.6% 86
17 0.15 2.76 1.37 4.6% 86
18 0.19 11.65* 1.44 5.6% 115
19 0.11 4.18 1.21 5.2% 102
20 0.29* 9.35* 0.97 5.6% 115

*in us-CRP indicates that the levels corresponded to high risk for acute phase inflammatory diseases, and in the TSH, free T4 and EMG column that the value was outside the range of reference.